pTau217 Antibody
Alzheimer's disease detection
IVDActive
Key Facts
About ALZpath
ALZpath provides a proprietary pTau217 antibody that powers early, blood‑based Alzheimer’s disease detection for diagnostics partners.
View full company profileTherapeutic Areas
Other Alzheimer's disease detection Drugs
| Drug | Company | Phase |
|---|---|---|
| SOBA-AD | AltPep | Preclinical |
| LucentAD Complete | Quanterix | FDA 510(k) Submission |
| SavaDx | Cassava Sciences | Research |